Enanta Pharmaceuticals
ENTA
ENTA
129 hedge funds and large institutions have $296M invested in Enanta Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 49 increasing their positions, 47 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
29% less capital invested
Capital invested by funds: $414M → $296M (-$118M)
59% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 34
Holders
129
Holding in Top 10
1
Calls
$1.04M
Puts
$614K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$11.9M | |
| 3 | +$5.29M | |
| 4 |
SIM
Spark Investment Management
New York
|
+$4.86M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$3.16M |
Top Sellers
| 1 | -$7.33M | |
| 2 | -$4.89M | |
| 3 | -$4.73M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.6M |
| 5 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$2.5M |